Total Payments
$4,794
2024 Payments
$1,122
Companies
19
Transactions
151
Medicare Patients
6,800
Medicare Billing
$3.3M
Payment Breakdown by Category
Food & Beverage$4,727 (98.6%)
Education$67.22 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,727 | 148 | 98.6% |
| Education | $67.22 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,208 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $883.78 | 24 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $400.77 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $346.88 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $335.88 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $335.28 | 18 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $251.43 | 11 | $0 (2022) |
| OPKO Pharmaceuticals, LLC | $177.38 | 11 | $0 (2024) |
| Ardelyx, Inc. | $162.54 | 5 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $125.63 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,122 | 38 | AstraZeneca Pharmaceuticals LP ($369.78) |
| 2023 | $864.02 | 24 | AstraZeneca Pharmaceuticals LP ($254.34) |
| 2022 | $639.66 | 20 | Amgen Inc. ($296.83) |
| 2021 | $408.73 | 16 | AbbVie Inc. ($125.00) |
| 2020 | $329.03 | 13 | Amgen Inc. ($163.34) |
| 2019 | $939.87 | 26 | Amgen Inc. ($378.71) |
| 2018 | $491.31 | 14 | Otsuka America Pharmaceutical, Inc. ($181.82) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 2 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Nephrology | ||||||
| 04/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Cardio-renal | ||||||
| 04/10/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Nephrology | ||||||
| 03/29/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Nephrology | ||||||
| 03/21/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: NEPHROLOGY | ||||||
| 03/14/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Nephrology | ||||||
| 03/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2024 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: Nephrology | ||||||
| 02/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Cardio-renal | ||||||
| 01/27/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: NEPHROLOGY | ||||||
| 01/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), LOKELMA | Food and Beverage | In-kind items and services | $153.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardio-renal | ||||||
| 11/01/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 10/21/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Nephrology | ||||||
| 10/13/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Cardio-renal | ||||||
| 10/11/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: NEPHROLOGY | ||||||
| 09/15/2023 | Amgen Inc. | Parsabiv (Drug), TAVNEOS | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Nephrology | ||||||
| 08/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: DIABETES | ||||||
| 08/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/28/2023 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: Nephrology | ||||||
| 07/06/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Nephrology | ||||||
| 06/23/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,719 | 6,490 | $2.2M | $760,140 |
| 2022 | 11 | 1,844 | 8,508 | $2.7M | $892,525 |
| 2021 | 11 | 1,743 | 10,064 | $3.3M | $965,532 |
| 2020 | 10 | 1,494 | 7,023 | $2.5M | $682,760 |
Total Patients
6,800
Total Services
32,085
Medicare Billing
$3.3M
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 110 | 955 | $891,701 | $284,232 | 31.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 440 | 3,226 | $645,200 | $213,885 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 320 | 820 | $164,000 | $85,664 | 52.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 211 | 747 | $212,895 | $74,493 | 35.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 374 | 455 | $182,000 | $66,148 | 36.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $34,800 | $15,773 | 45.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 38 | 48 | $32,875 | $11,901 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 52 | $9,440 | $4,049 | 42.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 41 | 47 | $10,340 | $2,806 | 27.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 24 | $2,400 | $1,189 | 49.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 552 | 5,223 | $1.1M | $316,061 | 29.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 110 | 947 | $875,975 | $289,871 | 33.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 496 | 597 | $249,320 | $100,199 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 252 | 725 | $161,280 | $71,003 | 44.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 235 | 711 | $205,345 | $61,723 | 30.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 11 | 90 | $83,250 | $22,525 | 27.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 36 | 46 | $30,950 | $11,740 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $27,800 | $11,701 | 42.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 17 | 20 | $12,900 | $3,528 | 27.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 31 | 38 | $8,370 | $2,348 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 25 | $4,375 | $1,825 | 41.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 623 | 7,643 | $1.7M | $479,089 | 27.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 108 | 796 | $736,300 | $248,102 | 33.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 552 | 749 | $486,850 | $130,154 | 26.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 175 | 385 | $134,750 | $40,561 | 30.1% |
About Dr. Hone Kaw, M.D
Dr. Hone Kaw, M.D is a Nephrology healthcare provider based in Monterey Park, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2013. The National Provider Identifier (NPI) number assigned to this provider is 1750729588.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hone Kaw, M.D has received a total of $4,794 in payments from pharmaceutical and medical device companies, with $1,122 received in 2024. These payments were reported across 151 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,727).
As a Medicare-enrolled provider, Kaw has provided services to 6,800 Medicare beneficiaries, totaling 32,085 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Monterey Park, CA
- Active Since 06/14/2013
- Last Updated 08/08/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1750729588
Products in Payments
- FARXIGA (Drug) $550.29
- Parsabiv (Drug) $427.56
- Parsabiv (Biological) $399.75
- Kerendia (Drug) $335.28
- LOKELMA (Drug) $333.49
- Auryxia (Drug) $298.06
- Repatha (Biological) $249.47
- JARDIANCE (Drug) $246.62
- ACTHAR (Biological) $194.46
- JYNARQUE (Drug) $127.36
- DALVANCE (Drug) $125.00
- ZERBAXA (Drug) $124.89
- RECARBRIO (Drug) $124.73
- AVYCAZ (Drug) $124.48
- SAMSCA (Drug) $124.07
- RAYALDEE (Drug) $121.06
- Aimovig (Biological) $106.88
- AURYXIA (Drug) $102.71
- XPHOZAH 30 MG (Drug) $100.25
- STEGLATRO (Drug) $97.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Monterey Park
Dr. Adam Sun, Md, MD
Nephrology — Payments: $5,568
Nephrology $5,568
Dr. Carlos Meza, M.d, M.D
Nephrology — Payments: $4,593
Nephrology $4,593
Jim-Jer Hwu, Md, MD
Nephrology — Payments: $3,625
Nephrology $3,625
Than Lin, D.o, D.O
Nephrology — Payments: $3,211
Nephrology $3,211
Josephine Hwu, Md, MD
Nephrology — Payments: $677.82
Nephrology $677.82
Dr. Shih Hsu, M.d, M.D
Nephrology — Payments: $497.83
Nephrology $497.83